New hope for calming cancer Patients' distressing confusion
NCT ID NCT01949662
Summary
This study aims to find the best way to quickly calm severe agitation and confusion (delirium) in hospitalized patients with advanced cancer who are receiving comfort-focused care. Researchers are testing whether adding a single dose of the sedative lorazepam to the standard medication haloperidol works better than haloperidol alone. The goal is to help patients feel more comfortable and less distressed during a difficult time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED CANCERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.